As indicated in Figure 3, positive feedback loops connecting high-calorie/fat meals, overweight/obesity, mitochondrial OxS, skeletal muscle insulin resistance, increased glycemia, and systemic OxS are likely at play in T2D
Non-steroidal anti-inflammatory drugs (NSAIDs), statins, glucocorticoids and monoclonal antibodies (e.g., targeting IL-6, TNF-, IL-12/23) have been reported to show moderate anti-depressant capacity in patients with somatic disorders (i.e., rheumatoid arthritis, psoriasis) who also had comorbid symptoms of depression [194, 195]
Channel strategy has become the primary determinant of brand scale and profitability
For those managing a confirmed deficiency rather than simply maintaining levels, the treatment approach shifts significantly